Stem Cells http://www.stemcellsportal.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


First published online February 7, 2008
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
2007-0562v1
26/4/1017    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marsboom, G.
Right arrow Articles by Janssens, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marsboom, G.
Right arrow Articles by Janssens, S.
Submitted on July 13, 2007
Accepted on January 25, 2008

TISSUE-SPECIFIC STEM CELLS

Sustained Endothelial Progenitor Cell Dysfunction after Chronic Hypoxia-Induced Pulmonary Hypertension

Glenn Marsboom 1, Peter Pokreisz 1, Olivier Gheysens 1, Pieter Vermeersch 1, Hilde Gillijns 1, Marijke Pellens 1, Xiaoshun Liu 1, Désiré Collen 1, Stefan Janssens 2*

1 Center for Transgene Technology and Gene Therapy, Flanders Institute for Biotechnology (VIB), K.U.Leuven, Leuven, Belgium
2 Center for Transgene Technology and Gene Therapy, Flanders Institute for Biotechnology (VIB), K.U.Leuven, Leuven, Belgium; Cardiology Division, University Hospital Gasthuisberg, K.U.Leuven, Leuven, Belgium.

* To whom correspondence should be addressed. E-mail: stefan.janssens{at}med.kuleuven.be.


   Abstract

Circulating endothelial progenitor cells (EPCs) contribute to neovascularization of ischemic tissues and repair of injured endothelium. The role of bone marrow-derived progenitor cells in hypoxia-induced pulmonary vascular remodeling and their tissue-engineering potential in pulmonary hypertension (PH) remains largely unknown. We studied endogenous mobilization and homing of EPCs in green fluorescent protein bone marrow chimeric mice exposed to chronic hypoxia (CHx), a common hallmark of PH. Despite increased peripheral mobilization, as shown by flow cytometry and EPC culture, bone marrow-derived endothelial cell recruitment in remodeling lung vessels was limited. Moreover, transfer of VEGFR-2+/Sca-1+/CXCR-4+ cultured early outgrowth EPCs failed to reverse PH, suggesting hypoxia-induced functional impairment of transferred EPCs. CHx decreased migration to SDF-1{alpha}, adhesion to fibronectin, incorporation into a vascular network, and nitric oxide production (-41%, -29%, -30%, and -32%, respectively, versus normoxic EPCs, P<0.05 for all). The dysfunctional phenotype of hypoxic EPCs significantly impaired their neovascularization capacity in chronic hindlimb ischemia, contrary to normoxic EPCs cultured in identical conditions. Mechanisms contributing to EPC dysfunction include reduced integrin {alpha}v and {beta}1 expression, decreased mitochondrial membrane potential, and enhanced senescence. Novel insights from chronic hypoxia-induced EPC dysfunction may provide important cues for improved future cell repair strategies.

Key Words. Endothelial Progenitor Cells, Cell Transplantation, Bone Marrow Transplantation, Pulmonary Hypertension, Microvasculature, Chronic Hypoxia







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.stemcellsportal.com/
Copyright © 2008 by AlphaMed Press.